OUR INNOVATIVE TECHNOLOGY
We are enabling a step-change in the discovery of novel therapeutics for highly heterogenous disease conditions, including immune disorders, cancers, and infectious disease.
Our technology provides, for the first time:
- deep analysis of individual cell function of 10M-1Bn individual living cells
- very large scale, cell by cell combinational biology studying healthy tissue, disease biology, and immune function simultaneously, allowing for therapeutic insight across millions or billions of cells
-clinical decision assistance based on statistical and machine analysis across millions or billions of cell results – for example from patient tumour biopsies
- sequencing, replication or banking of post-assay biology for therapeutic design or long term asset building
“It always seems impossible until it’s done.”